Abstract
The development of new drugs or formulations for the treatments of different musculoskeletal disorders (MSDs) has now being a focus of pharmaceutical and scientific societies. Targeted and multidelivery of drug and key minerals to support bone repair and regeneration at the defect site, from flexible biodegradable devices at the rate within the therapeutic window, seem to be an effective strategy. However, the drug delivery vehicles available are neither flexible and degradable nor able to deliver both pharmaceutical drug and minerals effectively. The use of biodegradable polymer and bioceramic for composite development with enough flexibility and potential for slow in situ drug delivery for biomedical applications could be one of the real options to mitigate MSDs problem. In vitro analysis of the developed devices is a vital step towards clinical trial and commercialization of the implant. Different approach and results have been compared to draw guidelines for the development and testing of thin film composite applications as a slow drug delivery vehicle.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Li C, Zheng Y, Wang X, et al. J Cell Physiol. 2012;227:2805.
Macha IJ, Cazalbou S, Ben-Nissan B, Harvey KL, Milthorpe B. Mar Drugs. 2015;13:666. doi:10.3390/md13010666.
Macha IJ, Cazalbou S, Shimmon R, Ben-Nissan B, Milthorpe B. Development and dissolution studies of bisphosphonate (clodronate) containing hydroxyapatite/PLA biocomposites for slow drug delivery. J Tissue Eng Regen Med. 2015. doi: 10.1002/term.2066. [Epub ahead of print].
Hench LL. Bioceramics: from concept to clinic. J Am Ceram Soc. 1991;74(7):1487–510.
Suchanek W, Yoshimura M. J Mater Res. 1998;13:94. doi:10.1557/JMR.1998.0015.
Chai CS, Ben-Nissan B. J Mater Sci Mater Med. 1999;10:465.
Choi AH, Ben-Nissan B. Nanomedicine. 2007;2:51. doi:10.2217/17435889.2.1.51.
Macha IJ, Ben-Nissan B, Milthorpe B. Curr Nanosci. 2014;10:200.
Drumright RE, Gruber PR, Henton DE. Adv Mater. 2000;12:1841. doi:10.1002/1521-4095(200012)12:23<1841::aid-adma1841>3.0.co;2-e.
Liu P, Ouyang Y, Xiao R. International forum on biomedical textile materials, proceedings: 298. 2010.
Södergård A, Stolt M. Prog Polym Sci. 2002;27:1123. doi:10.1016/s0079-6700(02)00012-6.
De Santis P, Kovacs AJ. Biopolymers. 1968;6:299. doi:10.1002/bip.1968.360060305.
Gupta AP, Kumar V. Eur Polym J. 2007;43:4053. doi:10.1016/j.eurpolymj.2007.06.045.
Lasprilla AJR, Martinez GAR, Lunelli BH, Jardini AL, Filho RM. Biotechnol Adv. 2012;30:321. doi:10.1016/j.biotechadv.2011.06.019.
Peltola T, Jokinen M, Veittola S, Simola J, Yli-Urpo A. J Biomed Mater Res. 2001;54:579.
LeGeros RZ. Chem Rev. 2008;108:4742. doi:10.1021/cr800427g.
LeGeros RZ. Clin Orthop Relat Res. 2002:81.
LeGeros RZ. Calcium phosphate materials in restorative dentistry: a review. Adv Dent Res. 1988;2(1):164–80.
Best SM, Porter AE, Thian ES, Huang J. J Eur Ceram Soc. 2008;28:1319. http://dx.doi.org/10.1016/j.jeurceramsoc.2007.12.001
Ben-Nissan B. Curr Opin Solid State Mater Sci. 2003;7:283.
Macha IJ, Ozyegin LS, Chou J, Samur R, Oktar FN, Ben-Nissan B. J Aust Ceram Soc. 2013;49:122.
Macha IJ, Ozyegin LS, Oktar FN, Ben-Nissan B. J Aust Ceram Soc. 2015;51
Oktar F, Tuyel U, Demirkol N, et al. Artificial organs conference, FYROM, 2010 International Journal of Artificial Organs, (Special Issue). 2010.
Green DW, Ben-Nissan B. Biomimetic applications in regenerative medicine: scaffolds, transplantation modules, tissue homing device and stem cells. In: Tochilin V, Amiji M, editors. Handbook of materials for nanomedicine. Singapore: Pan Stanford Publishing Pte Ltd; 2010. p. 821–50.
Ben-Nissan B, Milev A, Vago R. Biomaterials. 2004;25:4971. doi:10.1016/j.biomaterials.2004.02.006.
Ben-Nissan B. MRS Bull. 2004;29:28.
Kuhne JH, Bartl R, Frisch B, Hammer C, Jansson V, Zimmer M. Acta Orthop Scand. 1994:65.
Heness G, Ben-Nissan B. Mater Forum. 2004;27:104.
Macha IJ, Boonyang U, Cazalbou S, et al. J Aust Ceram Soc. 2015;51:149.
Chou J, Valenzuela S, Green DW, et al. Nanomedicine. 2014;9:1131. doi:10.2217/nnm.13.116.
Zhu M, Wang H, Liu J, et al. Biomaterials. 2011;32:1986. doi:10.1016/j.biomaterials.2010.11.025.
Ginebra M-P, Canal C, Espanol M, Pastorino D, Montufar EB. Adv Drug Deliv Rev. 2012;64:1090. doi:10.1016/j.addr.2012.01.008.
Batycky RP, Hanes J, Langer R, Edwards DA. J Pharm Sci. 1997;86:1464. doi:10.1021/js9604117.
Pascaud P, Bareille R, Bourget C, Amedee J, Rey C, Sarda S. Biomed Mater. 2012;7:054108. doi:10.1088/1748-6041/7/5/054108.
Palacio ML, Bhushan B. Philos Trans Ser A Math Phys Eng Sci. 2012;370:2321. doi:10.1098/rsta.2011.0483.
Noh H, Vogler EA. Biomaterials. 2007;28:405. http://dx.doi.org/10.1016/j.biomaterials.2006.09.006
Garcia AJ, Keselowsky BG. Critical reviews in eukaryotic. Gene Exp. 2002;12:151.
Keselowsky BG, Collard DM, Garcia AJ. J Biomed Mater Res B. 2003;66:247. doi:10.1002/jbm.a.10537.
Alvarez-Barreto JF, Landy B, VanGordon S, Place L, DeAngelis PL, Sikavitsas VI. J Tissue Eng Regen Med. 2011;5:464. doi:10.1002/term.338.
Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. Biomaterials. 2012;33:5967. http://dx.doi.org/10.1016/j.biomaterials.2012.05.031
Klevens RM, Edwards JR, Richards Jr CL, et al. Public Health Rep (Washington, DC: 1974). 2007;122:160.
Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. J Hosp Infect. 2009;72:97. http://dx.doi.org/10.1016/j.jhin.2008.12.012
Vert M, Doi Y, Hellwich K-H, et al. Pure Appl Chem. 2012;84:34.
Stewart PS. Int J Med Microbiol. 2002;292:107. http://dx.doi.org/10.1078/1438-4221-00196
Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Int J Antimicrob Agents. 2010;35:322. doi:10.1016/j.ijantimicag.2009.12.011.
Marshall BC, Hazl L. Cystic fibrosis patient registry annual data report. Bethesda: Cystic Fibrosis Foundation. 2011.
von Eiff C, Jansen B, Kohnen W, Becker K. Drugs. 2005;65:179.
Heydorn A, Nielsen AT, Hentzer M, et al. Microbiology. 2000;146(Pt 10):2395.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Macha, I.J., Ben-Nissan, B., Choi, A., Cazalbou, S. (2017). Development and In Vitro Analysis of a New Biodegradable PLA/Hydroxyapatite (HAp) Composite for Biomedical Applications. In: Kaur, G. (eds) Clinical Applications of Biomaterials. Springer, Cham. https://doi.org/10.1007/978-3-319-56059-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-56059-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56058-8
Online ISBN: 978-3-319-56059-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)